Legend Biotech (LEGN) Divestments (2019 - 2023)

Legend Biotech has reported Divestments for 5 years, with the latest figure at $407.5 million in Q4 2023.

• For the quarter ending Q4 2023, Divestments rose 1534.48% year-over-year to $407.5 million; the trailing twelve-month figure through Dec 2023 stood at $590.1 million (up 99.32% YoY), and the FY2023 full-year result was $92.8 million, up 220.36% from the prior year.
• Divestments for Q4 2023 stood at $407.5 million, up from $24.9 million in the prior quarter.
• The five-year high for Divestments was $407.5 million in Q4 2023, with the low at $24.9 million in Q4 2022.
• Historically, Divestments has averaged $140.7 million across 5 years, with a median of $96.5 million in 2021.
• Annual changes were most pronounced in 2022 — Divestments sank 74.17% — and 2023, when it surged 1534.48%.
• Legend Biotech's Divestments stood at $113.5 million in 2019, then slumped by 46.09% to $61.2 million in 2020, then surged by 57.79% to $96.5 million in 2021, then slumped by 74.17% to $24.9 million in 2022, then surged by 1534.48% to $407.5 million in 2023.
• The last three Divestments figures came in at $407.5 million (Q4 2023), $24.9 million (Q4 2022), and $96.5 million (Q4 2021), per Business Quant data.